Annual Accounts Receivable
$6.57 B
+$347.00 M+5.58%
31 December 2023
Summary:
Abbott Laboratories annual accounts receivable is currently $6.57 billion, with the most recent change of +$347.00 million (+5.58%) on 31 December 2023. During the last 3 years, it has risen by +$151.00 million (+2.35%). ABT annual accounts receivable is now -14.56% below its all-time high of $7.68 billion, reached on 31 December 2011.ABT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$7.05 B
+$197.00 M+2.87%
30 September 2024
Summary:
Abbott Laboratories quarterly accounts receivable is currently $7.05 billion, with the most recent change of +$197.00 million (+2.87%) on 30 September 2024. Over the past year, it has increased by +$552.00 million (+8.49%). ABT quarterly accounts receivable is now -8.24% below its all-time high of $7.68 billion, reached on 31 December 2011.ABT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Accounts Receivable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.6% | +8.5% |
3 y3 years | +2.4% | +10.1% |
5 y5 years | +26.7% | +29.4% |
ABT Accounts Receivable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +5.6% | -2.1% | +17.1% |
5 y | 5 years | at high | +26.7% | -2.1% | +37.2% |
alltime | all time | -14.6% | +427.6% | -8.2% | +466.6% |
Abbott Laboratories Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $7.05 B(+2.9%) |
June 2024 | - | $6.85 B(+3.8%) |
Mar 2024 | - | $6.61 B(+0.6%) |
Dec 2023 | $6.57 B(+5.6%) | $6.57 B(+1.0%) |
Sept 2023 | - | $6.50 B(+5.3%) |
June 2023 | - | $6.17 B(+2.5%) |
Mar 2023 | - | $6.02 B(-3.2%) |
Dec 2022 | $6.22 B(-4.1%) | $6.22 B(-3.0%) |
Sept 2022 | - | $6.41 B(-11.0%) |
June 2022 | - | $7.20 B(+0.3%) |
Mar 2022 | - | $7.18 B(+10.7%) |
Dec 2021 | $6.49 B(+1.1%) | $6.49 B(+1.3%) |
Sept 2021 | - | $6.41 B(+4.8%) |
June 2021 | - | $6.11 B(+0.3%) |
Mar 2021 | - | $6.10 B(-5.0%) |
Dec 2020 | $6.41 B(+18.2%) | $6.41 B(+13.5%) |
Sept 2020 | - | $5.65 B(+9.9%) |
June 2020 | - | $5.14 B(-2.9%) |
Mar 2020 | - | $5.29 B(-2.5%) |
Dec 2019 | $5.42 B(+4.7%) | $5.42 B(-0.5%) |
Sept 2019 | - | $5.45 B(-1.8%) |
June 2019 | - | $5.55 B(+3.8%) |
Mar 2019 | - | $5.34 B(+3.1%) |
Dec 2018 | $5.18 B(-1.3%) | $5.18 B(-1.7%) |
Sept 2018 | - | $5.27 B(+1.5%) |
June 2018 | - | $5.19 B(-3.1%) |
Mar 2018 | - | $5.36 B(+2.0%) |
Dec 2017 | $5.25 B(+61.6%) | $5.25 B(+9.4%) |
Sept 2017 | - | $4.80 B(+3.6%) |
June 2017 | - | $4.63 B(+2.7%) |
Mar 2017 | - | $4.51 B(+38.9%) |
Dec 2016 | $3.25 B(-5.0%) | $3.25 B(-2.2%) |
Sept 2016 | - | $3.32 B(-6.9%) |
June 2016 | - | $3.57 B(+4.0%) |
Mar 2016 | - | $3.43 B(+0.4%) |
Dec 2015 | $3.42 B(-4.7%) | $3.42 B(-1.2%) |
Sept 2015 | - | $3.46 B(-2.6%) |
June 2015 | - | $3.55 B(+2.1%) |
Mar 2015 | - | $3.48 B(-2.9%) |
Dec 2014 | $3.59 B(-10.0%) | $3.59 B(-0.9%) |
Sept 2014 | - | $3.62 B(-10.8%) |
June 2014 | - | $4.06 B(+4.5%) |
Mar 2014 | - | $3.88 B(-2.6%) |
Dec 2013 | $3.99 B(-47.6%) | $3.99 B(+2.7%) |
Sept 2013 | - | $3.88 B(-1.4%) |
June 2013 | - | $3.94 B(+0.5%) |
Mar 2013 | - | $3.92 B(-48.5%) |
Dec 2012 | $7.61 B(-0.9%) | $7.61 B(+9.6%) |
Sept 2012 | - | $6.95 B(+2.7%) |
June 2012 | - | $6.77 B(-11.6%) |
Mar 2012 | - | $7.66 B(-0.3%) |
Dec 2011 | $7.68 B(+7.0%) | $7.68 B(+9.1%) |
Sept 2011 | - | $7.04 B(+0.1%) |
June 2011 | - | $7.04 B(-1.7%) |
Mar 2011 | - | $7.16 B(-0.3%) |
Dec 2010 | $7.18 B(+9.8%) | $7.18 B(+15.0%) |
Sept 2010 | - | $6.25 B(-1.4%) |
June 2010 | - | $6.34 B(-2.8%) |
Mar 2010 | - | $6.52 B(-0.3%) |
Dec 2009 | $6.54 B | $6.54 B(+19.5%) |
Sept 2009 | - | $5.47 B(+0.4%) |
June 2009 | - | $5.45 B(+4.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2009 | - | $5.23 B(+4.7%) |
Sept 2008 | - | $4.99 B(-3.8%) |
June 2008 | - | $5.19 B(+3.8%) |
Mar 2008 | - | $5.00 B(+1.0%) |
Dec 2007 | $4.95 B(+16.9%) | $4.95 B(+17.5%) |
Sept 2007 | - | $4.21 B(+24.0%) |
June 2007 | - | $3.40 B(+3.6%) |
Mar 2007 | - | $3.28 B(-22.5%) |
Dec 2006 | $4.23 B(+18.3%) | $4.23 B(+18.3%) |
Sept 2006 | - | $3.58 B(-2.6%) |
June 2006 | - | $3.67 B(+9.9%) |
Mar 2006 | - | $3.34 B(-6.5%) |
Dec 2005 | $3.58 B(-3.2%) | $3.58 B(+11.7%) |
Sept 2005 | - | $3.20 B(-4.3%) |
June 2005 | - | $3.35 B(-5.4%) |
Mar 2005 | - | $3.54 B(-4.3%) |
Dec 2004 | $3.70 B(+11.6%) | $3.70 B(+25.5%) |
Sept 2004 | - | $2.95 B(+3.0%) |
June 2004 | - | $2.86 B(-10.6%) |
Mar 2004 | - | $3.20 B(-3.4%) |
Dec 2003 | $3.31 B(+13.2%) | $3.31 B(+15.0%) |
Sept 2003 | - | $2.88 B(+1.7%) |
June 2003 | - | $2.83 B(+2.6%) |
Mar 2003 | - | $2.76 B(-5.6%) |
Dec 2002 | $2.93 B(+4.1%) | $2.93 B(+2.2%) |
Sept 2002 | - | $2.87 B(+1.4%) |
June 2002 | - | $2.83 B(+6.9%) |
Mar 2002 | - | $2.64 B(-6.0%) |
Dec 2001 | $2.81 B(+29.1%) | $2.81 B(+4.6%) |
Sept 2001 | - | $2.69 B(+7.9%) |
June 2001 | - | $2.49 B(-2.5%) |
Mar 2001 | - | $2.55 B(+17.2%) |
Dec 2000 | $2.18 B(+6.0%) | $2.18 B(+7.4%) |
Sept 2000 | - | $2.03 B(-0.5%) |
June 2000 | - | $2.04 B(+5.1%) |
Mar 2000 | - | $1.94 B(-5.6%) |
Dec 1999 | $2.06 B(+5.1%) | $2.06 B(+9.2%) |
Sept 1999 | - | $1.88 B(-1.4%) |
June 1999 | - | $1.91 B(-3.7%) |
Mar 1999 | - | $1.98 B(+1.4%) |
Dec 1998 | $1.96 B(+9.7%) | $1.96 B(+12.9%) |
Sept 1998 | - | $1.73 B(-1.5%) |
June 1998 | - | $1.76 B(+3.4%) |
Mar 1998 | - | $1.70 B(-4.5%) |
Dec 1997 | $1.78 B(+4.3%) | $1.78 B(+4.8%) |
Sept 1997 | - | $1.70 B(-1.7%) |
June 1997 | - | $1.73 B(-0.1%) |
Mar 1997 | - | $1.73 B(+1.3%) |
Dec 1996 | $1.71 B(+9.3%) | $1.71 B(+10.3%) |
Sept 1996 | - | $1.55 B(-5.7%) |
June 1996 | - | $1.64 B(+5.2%) |
Mar 1996 | - | $1.56 B(-0.0%) |
Dec 1995 | $1.56 B(+6.4%) | $1.56 B(+6.3%) |
Sept 1995 | - | $1.47 B(-3.2%) |
June 1995 | - | $1.52 B(-1.9%) |
Mar 1995 | - | $1.55 B(+5.5%) |
Dec 1994 | $1.47 B(+9.9%) | $1.47 B(-0.2%) |
Sept 1994 | - | $1.47 B(+2.7%) |
June 1994 | - | $1.43 B(+6.2%) |
Mar 1994 | - | $1.35 B(+1.1%) |
Dec 1993 | $1.34 B(+7.4%) | $1.34 B(+7.4%) |
Dec 1992 | $1.24 B | $1.24 B |
FAQ
- What is Abbott Laboratories annual accounts receivable?
- What is the all time high annual accounts receivable for Abbott Laboratories?
- What is Abbott Laboratories annual accounts receivable year-on-year change?
- What is Abbott Laboratories quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Abbott Laboratories?
- What is Abbott Laboratories quarterly accounts receivable year-on-year change?
What is Abbott Laboratories annual accounts receivable?
The current annual accounts receivable of ABT is $6.57 B
What is the all time high annual accounts receivable for Abbott Laboratories?
Abbott Laboratories all-time high annual accounts receivable is $7.68 B
What is Abbott Laboratories annual accounts receivable year-on-year change?
Over the past year, ABT annual accounts receivable has changed by +$347.00 M (+5.58%)
What is Abbott Laboratories quarterly accounts receivable?
The current quarterly accounts receivable of ABT is $7.05 B
What is the all time high quarterly accounts receivable for Abbott Laboratories?
Abbott Laboratories all-time high quarterly accounts receivable is $7.68 B
What is Abbott Laboratories quarterly accounts receivable year-on-year change?
Over the past year, ABT quarterly accounts receivable has changed by +$552.00 M (+8.49%)